This insider cluster is routine and non-informative. The CEO and CFO are exercising options and selling a small fraction of the resulting shares, likely for tax or liquidity purposes. No bearish signal. Monitor the next 10-Q for any guidance revision or pipeline setback, but this filing alone does not warrant action.
Price Chart
Executive Summary
Four UTHR insiders (CEO, CFO, EVP, Director) sold a total of ~$1.04M in open-market sales over a 7-day window following the Q1 2026 earnings release. The sales are small relative to the $24.4B market cap (~0.004%), and the CEO's and CFO's sales coincide with option exercises and tax-withholding transactions, suggesting routine portfolio management rather than a bearish signal. The cluster is not amplified by the earnings context because the sales are immaterial in size.
Key Financial Metrics
Key Facts
- Total open-market sales of ~$1.04M represent ~0.004% of UTHR's $24.4B market cap — well below the 0.1% materiality threshold.
- CEO Rothblatt sold 1,378 shares ($793K) on May 13, but concurrently exercised 9,500 options at $146.03/share ($1.39M), indicating a net cash-neutral position adjustment.
- CFO Edgemond sold 80 shares ($45K) on May 14 after exercising 10,000 options at $135.42/share ($1.35M) on May 11 and 14 — the sales are trivial relative to the option exercises.
- Director Mesa sold 258 shares ($150K) — a routine diversification trade.
- EVP Mahon sold 80 shares ($47K) — de minimis.
- The cluster follows Q1 2026 earnings (May 6) showing a 2% YoY revenue decline to $781.5M and a 15% net income decline to $274.9M — the insider sales are not reacting to new material information.
- All sales are open-market (code S) and occur after option exercises (code M) — consistent with tax-covering or cash-out patterns, not informed selling.
Financial Impact
Total insider sales of ~$1.04M are immaterial relative to $24.4B market cap — no financial impact.
Risk Factors
- Q1 2026 revenue declined 2% YoY and net income fell 15% — the underlying business fundamentals are softening, but this insider cluster does not add incremental negative signal.
- Tyvaso DPI growth (+9% YoY) is offset by Nebulized Tyvaso decline (-22%) and Remodulin decline (-8%), creating competitive uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1778879076624 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $552.73 (+10.47%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $552.73 (+11.19%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $552.73 (+9.70%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $552.73 (+9.06%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $552.73 (+13.36%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $552.73 (+13.23%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $552.73 (+7.23%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $552.73 (+4.70%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $552.73 (+6.98%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $552.73 (+6.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access